Skip to search formSkip to main contentSkip to account menu

European Treatment Outcome Study Score

Known as: EUTOS, European Treatment Outcome Study (EUTOS) Score 
A method for assessing prognosis for patients with chronic myeloid leukemia. Patients are classified as a high or low risk on the basis of the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Outcome of Frontline Treatment with “Generic” Imatinib In Adult Patients with Chronic Myeloid Leukemia in Algerian Population: A Multicenter Study
Introduction In a developing country like Algeria, such expensive therapy is not available. Alternative approaches are needed to… 
2017
2017
Smokers with chronic myeloid leukemia are at a higher risk of disease progression and premature death
Smoking is suspected to not only be a risk factor for chronic myeloid leukemia but an adverse prognostic factor for the disease… 
2016
2016
Chronic myeloid leukaemia in Spain: Its presentation characteristics have changed. Spanish section of the EUTOS population-based registry.
2015
2015
PTCH1 expression at diagnosis predicts imatinib failure in chronic myeloid leukaemia patients in chronic phase
The tyrosine kinase inhibitor (TKI) imatinib has revolutionized the management of chronic myeloid leukaemia (CML). However… 
Review
2015
Review
2015
Unfavorable outcome of chronic myelogenous leukemia in adolescent and young adults treated with tyrosine kinase inhibitors
Tyrosine kinase inhibitor (TKI) treatment has dramatically improved the outcome of chronic myelogenous leukemia in the chronic… 
2014
2014
The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid…
The introduction of tyrosine kinase inhibitors has dramatically improved outcomes for many patients with chronic myeloid leukemia… 
2012
2012
The EUTOS score identifies chronic myeloid leukeamia patients with poor prognosis treated with imatinib first or second line.
2012
2012
Comparison of Sokal, Hasford and EUTOS Scores in Terms of Long-Term Treatment Outcome According to the Risks in Each Prognostic Model: A Single Center Data Analyzed in 255 Early Chronic Phase Chronic…
Abstract 2794 Background The main difference of recently developed new prognostic classification, EUTOS score, from the… 
Highly Cited
2011
Highly Cited
2011
European Treatment and Outcome Study (EUTOS) score for chronic myeloid leukemia still requires more confirmation.
TO THEEDITOR: In 1984, Sokal et al 1 developed a scoring system to predict the outcome of patients with chronic myeloid leukemia… 
2011
2011
Prediction of Molecular Response of Chronic Phase CML Patients by the EUTOS Score: Results of the Randomized CML-Study IV,
Abstract 3762 Introduction: The EUTOS Score was developed and validated as a prognostic tool for the achievement of complete… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)